Drug-induced systemic lupus erythematosus.
D000927:Anticonvulsants / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008297:Male; D011342:Procainamide / Q000009:adverse effects
D000927:Anticonvulsants; D000959:Antihypertensive Agents; D014150:Antipsychotic Agents; D000995:Antitubercular Agents; D006830:Hydralazine; D011342:Procainamide